Table 3 Age at treatment initiation and treatment durations of NIV and LTOT
Years (mean ± SD) | All patients | COPD | NMD | RCWD | OHS | ILD | Misc* |
|---|---|---|---|---|---|---|---|
Age at NIV initiation | 58.7 ± 15.5 | 68.8 ± 7.9 | 46.9 ± 18.3 | 57.9 ± 17.3 | 59.8 ± 11.5 | 62.8 ± 7.8 | 52.2 ± 17.7 |
Age at LTOT initiation | 71.0 ± 12.0 | 72.0 ± 8.2 | 73.4 ± 17.5 | 65.3 ± 19.3 | 67.3 ± 9.2 | 73.5 ± 13.5 | 70.2 ± 15.9 |
NIV-treatment duration** | 7.0 ± 5.0 | 5.3 ± 3.5 | 8.4 ± 6.9 | 11.4 ± 7.2 | 6.5 ± 3.4 | 6.1 ± 2.8 | 6.4 ± 4.5 |
LTOT-treatment duration** | 4.9 ± 4.2 | 5.1 ± 3.3 | 5.6 ± 5.3 | 7.8 ± 6.4 | 6.0 ± 3.6 | 3.4 ± 3.1 | 4.7 ± 5.6 |
Lifetime of deceased patients (N = 368) | 75.4 ± 11.5 | 77.4 ± 8.1 | 61.4 ± 16.8 | 77.4 ± 13.5 | 72.2 ± 8.7 | 77.0 ± 1.8 | 76.7 ± 12.6 |